108 related articles for article (PubMed ID: 16600452)
1. Effect of carbamazepine on the single oral dose pharmacokinetics of perospirone and its active metabolite.
Masui T; Kusumi I; Takahashi Y; Koyama T
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1330-3. PubMed ID: 16600452
[TBL] [Abstract][Full Text] [Related]
2. Effects of itraconazole and tandospirone on the pharmacokinetics of perospirone.
Masui T; Kusumi I; Takahashi Y; Koyama T
Ther Drug Monit; 2006 Feb; 28(1):73-5. PubMed ID: 16418697
[TBL] [Abstract][Full Text] [Related]
3. Steady-state pharmacokinetics of a new antipsychotic agent perospirone and its active metabolite, and its relationship with prolactin response.
Yasui-Furukori N; Furukori H; Nakagami T; Saito M; Inoue Y; Kaneko S; Tateishi T
Ther Drug Monit; 2004 Aug; 26(4):361-5. PubMed ID: 15257064
[TBL] [Abstract][Full Text] [Related]
4. The wide variability of perospirone metabolism and the effect of perospirone on prolactin in psychiatric patients.
Suzuki Y; Sawamura K; Ono S; Fukui N; Sugai T; Watanabe J; Tsuneyama N; Inoue Y; Someya T
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Aug; 34(6):830-3. PubMed ID: 20363276
[TBL] [Abstract][Full Text] [Related]
5. Determination of a new atypical antipsychotic agent perospirone and its metabolite in human plasma by automated column-switching high-performance liquid chromatography.
Yasui-Furukori N; Inoue Y; Tateishi T
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jun; 789(2):239-45. PubMed ID: 12742115
[TBL] [Abstract][Full Text] [Related]
6. Long-term perospirone treatment with a single dose at bedtime in schizophrenia: relevant to intermittent dopamine D2 receptor antagonism.
Kusumi I; Masui T; Koyama T
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):520-2. PubMed ID: 18006133
[TBL] [Abstract][Full Text] [Related]
7. In vitro drug-drug interactions with perospirone and concomitantly administered drugs in human liver microsomes.
Shimakura J; Tani N; Mizuno Y; Komuro S; Kanamaru H
Eur J Drug Metab Pharmacokinet; 2003; 28(1):67-72. PubMed ID: 14503667
[TBL] [Abstract][Full Text] [Related]
8. Distribution of perospirone to melanin in pigmented rats.
Mizuno Y; Komuro S; Kanamaru H
Eur J Drug Metab Pharmacokinet; 2003; 28(1):73-9. PubMed ID: 14503668
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of carbamazepine against neuroleptic-induced akathisia in treatment with perospirone: case series.
Masui T; Kusumi I; Takahashi Y; Koyama T
Prog Neuropsychopharmacol Biol Psychiatry; 2005 Feb; 29(2):343-6. PubMed ID: 15694245
[TBL] [Abstract][Full Text] [Related]
10. Determination of perospirone by liquid chromatography/electrospray mass spectrometry: application to a pharmacokinetic study in healthy Chinese volunteers.
Ma N; Liu WY; Li HD; Zhu YG; Zhang BK; Wang F; Zhu RH; Xiang DX
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 847(2):210-6. PubMed ID: 17116433
[TBL] [Abstract][Full Text] [Related]
11. A novel antipsychotic, perospirone, has antiserotonergic and antidopaminergic effects in human brain: findings from neuroendocrine challenge tests.
Iwakawa M; Terao T; Soya A; Kojima H; Inoue Y; Ueda N; Yoshimura R; Nakamura J
Psychopharmacology (Berl); 2004 Nov; 176(3-4):407-11. PubMed ID: 15160263
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetics of perospirone hydrochloride at an excessive dose and changes in the serum prolactin level].
Ishii E; Otani N; Tsuchiya M; Kizu J; Ishimatsu S
Chudoku Kenkyu; 2007 Jan; 20(1):55-8. PubMed ID: 17319502
[TBL] [Abstract][Full Text] [Related]
13. Characterization of human cytochrome P450 enzymes involved in the in vitro metabolism of perospirone.
Kitamura A; Mizuno Y; Natsui K; Yabuki M; Komuro S; Kanamaru H
Biopharm Drug Dispos; 2005 Mar; 26(2):59-65. PubMed ID: 15619261
[TBL] [Abstract][Full Text] [Related]
14. Perospirone is a new generation antipsychotic: evidence from a positron emission tomography study of serotonin 2 and D2 receptor occupancy in the living human brain.
Sekine Y; Ouchi Y; Takei N; Yoshikawa E; Okada H; Minabe Y; Nakamura K; Suzuki K; Iwata Y; Tsuchiya KJ; Sugihara G; Mori N
J Clin Psychopharmacol; 2006 Oct; 26(5):531-3. PubMed ID: 16974201
[No Abstract] [Full Text] [Related]
15. In vivo occupation of dopamine D1, D2 and serotonin2A receptors by novel antipsychotic drug, SM-9018 and its metabolite, in rat brain.
Takahashi Y; Kusumi I; Ishikane T; Koyama T
J Neural Transm (Vienna); 1998; 105(2-3):181-91. PubMed ID: 9660096
[TBL] [Abstract][Full Text] [Related]
16. Effects of cytochrome P450 3A modulators ketoconazole and carbamazepine on quetiapine pharmacokinetics.
Grimm SW; Richtand NM; Winter HR; Stams KR; Reele SB
Br J Clin Pharmacol; 2006 Jan; 61(1):58-69. PubMed ID: 16390352
[TBL] [Abstract][Full Text] [Related]
17. Prolactin levels in schizophrenic patients receiving perospirone in comparison to risperidone.
Togo T; Iseki E; Shoji M; Oyama I; Kase A; Uchikado H; Katsuse O; Kosaka K
J Pharmacol Sci; 2003 Mar; 91(3):259-62. PubMed ID: 12686750
[TBL] [Abstract][Full Text] [Related]
18. Perospirone, a novel atypical antipsychotic drug, potentiates fluoxetine-induced increases in dopamine levels via multireceptor actions in the rat medial prefrontal cortex.
Yoshino T; Nisijima K; Shioda K; Yui K; Katoh S
Neurosci Lett; 2004 Jun; 364(1):16-21. PubMed ID: 15193747
[TBL] [Abstract][Full Text] [Related]
19. Prediction of CNS occupancy of dopamine D2 receptor based on systemic exposure and in vitro experiments.
Kanamitsu K; Arakawa R; Sugiyama Y; Suhara T; Kusuhara H
Drug Metab Pharmacokinet; 2016 Dec; 31(6):395-404. PubMed ID: 27745731
[TBL] [Abstract][Full Text] [Related]
20. Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors.
Hagiwara H; Fujita Y; Ishima T; Kunitachi S; Shirayama Y; Iyo M; Hashimoto K
Eur Neuropsychopharmacol; 2008 Jun; 18(6):448-54. PubMed ID: 18164909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
